Task force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management

Journal of the American College of Cardiology

Volumn 27, Issue 5, 1996, Pages 1007-1019

  Califf, Robert M ^b   Armstrong, Paul W ^b   Carver, Joseph R ^b   D'Agostino Sr , Ralph B ^b   Strauss, William E ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGINA PECTORIS; CEREBROVASCULAR DISEASE; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; HEART INFARCTION; HISTORY OF MEDICINE; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ADULT; AGED; FEMALE; MALE; MIDDLE AGED; PATIENT SELECTION; PROGNOSIS; REVIEW;

ADULT; AGED; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PROGNOSIS; RISK FACTORS;

EID: 0030115839     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(96)87733-3     Document Type: Conference Paper

References (68)

1. American Heart Association. Heart and Stroke Facts. Dallas: American Heart Association, 1994.
2. Siegel D, Grady D, Browner WS, Hulley SB. Risk factor modification after myocardial infarction. Ann Intern Med 1988;109:213-8.
3. Haskell WL, Alderman EL, Fair JM, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1994;89:975-90.
4. Goldman L, Gordon DJ, Rifkind BM, et al. Cost and health implications of cholesterol lowering. Circulation 1992;85:1960-8.
5. Mark DB. Assessment of prognosis in patients with coronary artery disease. In: Roubin GS, Califf RM, O'Neill WW, Phillips HR III, Stack RS, editors. Interventional Cardiovascular Medicine. Principles and Practice. New York: Churchill Livingstone; 1994:165-85.
6. Gordon T, Kannel WB. Multiple risk functions for predicting coronary heart disease: the concept, accuracy, and application. Am Heart J 1982;103: 1031-9.
7. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham study. Stroke 1991;22:312-8.
8. Smith KW, McKinlay SM, McKinlay JB. The validity of health risk appraisal for coronary heart disease: the results from a randomized field trial. Am J Public Health 1991;81:466-70.
9. Laurier D, Chau NP, Cazelles B, Segond P, PCV-METRA Group. Estimation of CHD risk in a French working population using a modified Framingham model. J Clin Epidemiol 1994;47:1353-64.
10. Gray D, Hampton JR, Shaw LK, Bernstein SJ, Pryor DB. Successful application of a predictive model of coronary diseases [abstract]. Circulation 1992;86 Suppl I:I-4.
11. Truett J, Cornfield J, Kannel W. A multivariate analysis of the risk of coronary heart disease in Framingham. J Chronic Dis 1967;20:511-24.
12. Daley J, Shwartz M. Developing risk-adjustment methods. In: lezzone LI, editor. Risk Adjustment for Measuring Health Care Outcomes. Ann Arbor (MI): Health Administration Press, 1994:199-238.
13. Hlatky MA, Califf RM, Harrell FE Jr, et al. Clinical judgment and therapeutic decision making. J Am Coll Cardiol 1990;15:1-14.
14. Selker HP, Griffith JL, D'Agostino RB. A time-insensitive predictive instrument for acute myocardial infarction mortality: a multicenter study. Med Care 1991;29:1196-211.
15. Kasper JF, Mulley AG, Wennberg JE. Developing shared decision-making programs to improve quality of health care. Qual Rev Bull 1992;18:183-90.
16. Emond M, Mock MB, Davis KB, et al. Long-term survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation 1994;90:2645-57.
17. Pryor DB, Shaw L, Harrell FE Jr, et al. Estimating the likelihood of severe coronary artery disease. Am J Med 1991;90:553-62.
18. Pryor DB, Shaw LK, McCants CB, et al. Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med 1993;118:81-90.
19. Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile: a statement for health professionals. Circulation 1991;83:356-62.
20. Gordon T. Garcia-Palmieri M, Kagn A, Kannel WB, Schiffman J. Differences in coronary heart disease in Framingham, Honolulu, and Puerto Rico. J Chronic Dis 1974;27:329-44.
21. Leaverton PE, Sorlie PD, Kleinman JC, et al. Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study. J Chronic Dis 1987;40:775-84.
22. Kannel WB, D'Agostino RB, Belanger AJ. Update on fibrinogen as a cardiovascular risk factor. Ann Epidemiol 1992;2:457-66.
23. D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication. Stroke 1994;25:40-3.
24. Braunwald E, Mark DB, Jones RH, et al. Unstable Angina: Diagnosis and Management. Rockville (MD): Agency for Health Care Policy and Research, 1994.
25. Gilpin EA, Koziol JA, Madsen EB, Henning H, Ross J Jr. Periods of differing mortality distribution during the first year after acute myocardial infarction. Am J Cardiol 1983;52:240-4.
26. Smith LR, Harrell FE, Jr., Rankin JS, et al. Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. Circulation 1991:84: Suppl III:III245-53.
27. Gibson RS. Non-Q-wave myocardial infarction: diagnosis, prognosis and management. Curr Probl Cardiol 1988;8:1-72.
28. Schroder R, Neuhaus KL, Linderer T, Bruggemann T, Tebbe V, Wegscheider K. Impact of late coronary artery reperfusion on left ventricular function one month after acute myocardial infarction: results of the ISAM study. Am J Cardiol 1989;64:878-84.
29. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-22.
30. Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
31. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993;328:673-9.
32. Califf RM, Mark DB, Harrell FE Jr, et al. Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease, J Am Coll Cardiol 1988;11:20-6.
33. Bounous EP Jr, Califf RM, Harrell FE Jr, et al. Prognostic value of the simplified Selvester QRS score in patients with coronary artery disease. J Am Coll Cardiol 1988;11:35-41.
34. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
35. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316:1429-35.
36. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1994;325:303-10.
37. Califf RM, Bounous P, Harrell FE, et al. The prognosis in the presence of coronary artery disease. In: Braunwald E, editor. Congestive Heart Failure: Current Research and Clinical Application. New York: Grune and Stratton, 1982:31-40.
38. Reigel MM, Hollier LH, Kazmier FJ, et al. Late survival in abdominal aortic aneurysm patients: the role of selective myocardial revascularization on the basis of clinical symptoms. J Vase Surg 1987;5:222-7.
39. Crawford ES, Bomberger RA, Glaeser DH, Saleh SA, Russell WL Aortoiliac occlusive disease: factors influencing survival and function following reconstructive operation over a twenty-five year period. Surgery 1981;90: 1055-67.
40. Gersh BJ, Rihal CS, Rooke TW, Ballard DJ. Evaluation and management of patients with both peripheral vascular and coronary artery disease. J Am Coll Cardiol 1991;18:203-14.
41. Ashton CM, Petersen NJ, Wray NP, et al. The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med 1993;118:204-10.
42. Detre KM, Peduzzi P, Hammermeister KE, Murphy ML, Hultgren HN, Takaro T. Five-year effect of medical and surgical therapy on resting left ventricular function in stable angina: Veterans Administration Cooperative Study. Am J Cardiol 1984;53:444-50.
43. Multicenter Post-Infarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:321-36.
44. Sanz G, Castaner A, Betriu A, et al. Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study. N Engl J Med 1982;306:1065-70.
45. Morris KG. Use of radionuclide angiography following acute myocardial infarction. In: Califf RM, Mark DB, Wagner GS, editors. Acute Coronary Care. 2nd ed, St. Louis: Mosby-Year Book, 1995:797-813.
46. Mark DB, Shaw L, Harrell FE Jr, et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med 1991;325:849-53.
47. Marmur JD, Freeman MR, Langer A, Armstrong PW. Prognosis in medically stabilized unstable angina: early Holter ST-segment monitoring compared with predischarge exercise thallium tomography. Ann Intern Med 1990;113:575-9.
48. Goodman SG, Freeman MR, Armstrong PW, Langer A. Does ambulatory monitoring contribute to exercise testing and myocardial perfusion scintigraphy in the prediction of the extent of coronary artery disease in stable angina? Am J Cardiol 1994;73:747-52.
49. Langer A, Minkowitz J, Dorian P, et al. Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group. J Am Coll Cardiol 1992;20:1313-7.
50. Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Miller DD. Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise. Am J Cardiol 1994;73:647-52.
51. Younis LT, Byers S, Shaw L, Barth G, Goodgold H, Chaitman BR. Prognostic importance of silent myocardial ischemia detected by intravenous dipyridamole thallium myocardial imaging in asymptomatic patients with coronary artery disease. J Am Coll Cardiol 1989;14:1635-41.
52. Shaw LJ, Eagle KA, Gersh BJ, Miller DD. Meta-analysis of intravenous dipyridamole thallium-201 imaging (1985-1994) and dobutamine echocardiography (1991-1994) for risk stratification prior to vascular surgery. J Am Coll Cardiol 1996;4:787-98.
53. Madu EC, Ahmar W, Arthur J, Fraker TD Jr. Clinical utility of digital dobutamine stress echocardiography in the noninvasive evaluation of coronary artery disease. Arch Intern Med 1994;154:1065-72.
54. Jones RH, McEwan P, Newman GE, et al. Accuracy of diagnosis of coronary artery disease by radionuclide measurement of left ventricular function during rest and exercise. Circulation 1981;64:586-601,
55. Johnson SH, Bigelow C, Lee KL, Pryor DB, Jones RH. Prediction of death and myocardial infarction by radionuclide angiocardiography in patients with suspected coronary artery disease. Am J Cardiol 1991;67:919-26.
56. Lee KL, Pryor DB, Pieper KS, et al. Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease: a comparison with clinical and catheterization variables. Circulation 1990;82: 1705-17.
57. Upton MT, Palmen ST, Jones RH. Assessment of left ventricular function by resting and exercise radionuclide angiocardiography following acute myocardial infarction. Am Heart J 1992;104:1232-43.
58. Pryor DB, Harrell FE, Jr., Lee KL, et al. Prognostic indicators from radionuclide angiography in medically treated patients with coronary artery disease. Am J Cardiol 1984;53:18-22.
59. Jones RH, Johnson SH, Bigelow C, et al. Exercise radionuclide angiography predicts cardiac death in patients with coronary artery disease. Circulation 1991;84 Suppl I:I-52-8.
60. Morris KG, Palmeri ST, Califf RM, et al. Value of radionuclide angiography for predicting specific cardiac events after acute myocardial infarction. Am J Cardiol 1985;55:318-24.
61. Kesler K, Shaw L, Heinle FK, Borges-Neto F, Jones R. Prognosis in patients with coronary artery disease by equilibrium radionuclide measurements of left ventricular function [abstract]. J Am Coll Cardiol 1996;27:286A.
62. Pryor DB, Bruce RA, Chaitman BR, et al. Task Force I: determination of prognosis in patients with ischemic heart disease. J Am Coll Cardiol 1989;14:1016-25.
63. Califf RM, Phillips HR, Hindman MC, et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol 1985;5:1055-63.
64. Mark DB, Nelson CL, Califf RM, et al. Continuing evolution of therapy for coronary artery disease: initial results from the era of coronary angioplasty. Circulation 1994;89:2015-25.
65. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994;344:563-70.
66. Califf RM, Harrell FE Jr, Lee KL, et al. The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. JAMA 1989;261:2077-86.
67. Mark DB, Hlatky MA, Harrell FE Jr, Lee KL, Califf RM, Pryor DB. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med 1987;106:793-800.
68. Silver MT, Rose GA, Paul SD, O'Donnell CJ, O'Gara PT, Eagle KA. A clinical rule to predict preserved left ventricular ejection fraction in patients after myocardial infarction. Ann Intern Med 1994;121:750-6.